Pharma Reaserch Prod Co Ltd (214450) - Total Liabilities

Latest as of December 2025: ₩320.01 Billion KRW ≈ $216.87 Million USD

Based on the latest financial reports, Pharma Reaserch Prod Co Ltd (214450) has total liabilities worth ₩320.01 Billion KRW (≈ $216.87 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Pharma Reaserch Prod Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

Pharma Reaserch Prod Co Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Pharma Reaserch Prod Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Pharma Reaserch Prod Co Ltd assets under control.

Pharma Reaserch Prod Co Ltd Competitors by Total Liabilities

The table below lists competitors of Pharma Reaserch Prod Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Stolt-Nielsen Limited LSE:0OHK	UK	Nkr3.35 Billion
Getac Technology Corp TW:3005	Taiwan	NT$22.82 Billion
Shenzhen China Micro Semicon Co. Ltd. A SHG:688380	China	CN¥304.00 Million
Qingdao Huicheng Environmental Co Ltd SHE:300779	China	CN¥4.81 Billion
Shanxi Meijin Energy Co Ltd SHE:000723	China	CN¥27.07 Billion
VGP NV BR:VGP	Belgium	€2.54 Billion
Carmila SA PA:CARM	France	€3.39 Billion
Jenoptik AG F:JEN	Germany	€732.81 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Pharma Reaserch Prod Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 214450 equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.46	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pharma Reaserch Prod Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pharma Reaserch Prod Co Ltd (2015–2025)

The table below shows the annual total liabilities of Pharma Reaserch Prod Co Ltd from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩320.01 Billion ≈ $216.87 Million	+11.79%
2024-12-31	₩286.26 Billion ≈ $193.99 Million	+291.67%
2023-12-31	₩73.09 Billion ≈ $49.53 Million	-45.68%
2022-12-31	₩134.55 Billion ≈ $91.18 Million	+10.10%
2021-12-31	₩122.20 Billion ≈ $82.82 Million	+64.23%
2020-12-31	₩74.41 Billion ≈ $50.43 Million	+22.28%
2019-12-31	₩60.85 Billion ≈ $41.24 Million	+0.47%
2018-12-31	₩60.56 Billion ≈ $41.04 Million	+494.87%
2017-12-31	₩10.18 Billion ≈ $6.90 Million	+32.38%
2016-12-31	₩7.69 Billion ≈ $5.21 Million	-38.76%
2015-12-31	₩12.56 Billion ≈ $8.51 Million	--

About Pharma Reaserch Prod Co Ltd

KQ:214450 Korea Biotechnology

Market Cap

$2.32 Billion

₩3.42 Trillion KRW

Market Cap Rank

#5676 Global

#128 in Korea

Share Price

₩329500.00

Change (1 day)

-0.45%

52-Week Range

₩259000.00 - ₩609000.00

All Time High

₩711000.00